D-galactosyl-β1-1'-D-erythro-sphingosine
>99%
- Product Code: 77551
CAS:
2238-90-6
| Molecular Weight: | 461.63 g./mol | Molecular Formula: | C₂₄H₄₇NO₇ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in the study of cellular processes and signaling pathways, particularly in understanding glycosphingolipid metabolism and its role in cell membrane structure and function. It is also utilized in research related to cancer, as glycosphingolipids are involved in tumor progression and metastasis. Additionally, it serves as a precursor for synthesizing more complex glycosphingolipids, aiding in the investigation of their biological roles and potential therapeutic applications. Its application extends to the development of biomarkers for various diseases, including neurodegenerative disorders, where glycosphingolipid imbalances are implicated.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | solid |
| PURITY | 99-100 |
| CARBON | 61.6 % 62.6 % |
| HYDROGEN BY ELEMENTAL ANALYSIS | 10 % 10.5 % |
| NITROGEN BY ELEMENTAL ANALYSIS | 2.8 % 3.2 % |
| OXYGEN BY ELEMENTAL ANALYSIS | 23.8 % 24.5 % |
| PROTON NMR SPECTRUM | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿12,990.00 |
+
-
|
D-galactosyl-β1-1'-D-erythro-sphingosine
Used in the study of cellular processes and signaling pathways, particularly in understanding glycosphingolipid metabolism and its role in cell membrane structure and function. It is also utilized in research related to cancer, as glycosphingolipids are involved in tumor progression and metastasis. Additionally, it serves as a precursor for synthesizing more complex glycosphingolipids, aiding in the investigation of their biological roles and potential therapeutic applications. Its application extends to the development of biomarkers for various diseases, including neurodegenerative disorders, where glycosphingolipid imbalances are implicated.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :